Your browser doesn't support javascript.
loading
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL.
Davies, John R; Hilton, Laura K; Jiang, Aixiang; Barrans, Sharon; Burton, Catherine; Johnson, Peter W M; Davies, Andrew J; Du, Ming-Qing; Tooze, Reuben; Cucco, Francesco; Care, Matthew A; Morin, Ryan D; Steidl, Christian; Sha, Chulin; Westhead, David R; Scott, David W.
Afiliação
  • Davies JR; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
  • Hilton LK; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Jiang A; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Barrans S; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Burton C; Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds Teaching Hospitals, Leeds, United Kingdom.
  • Johnson PWM; Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds Teaching Hospitals, Leeds, United Kingdom.
  • Davies AJ; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Du MQ; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Tooze R; Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Cucco F; Section of Experimental Haematology, University of Leeds, Leeds, United Kingdom.
  • Care MA; Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Morin RD; Institute of Clinical Physiology (IFC), Consiglio Nazionale delle Ricerche, Pisa, Italy.
  • Steidl C; Section of Experimental Haematology, University of Leeds, Leeds, United Kingdom.
  • Sha C; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Westhead DR; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Scott DW; Canada's Michael Smith Genome Sciences Centre, BC Cancer Research Centre, Vancouver, BC, Canada.
Blood Adv ; 7(20): 6156-6162, 2023 Oct 24.
Article em En | MEDLINE | ID: mdl-37595057

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biologia Tipo de estudo: Prognostic_studies Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biologia Tipo de estudo: Prognostic_studies Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article